01.24.23
Colorcon Inc., a leader in pharmaceutical film coatings and specialty excipients, has entered into a Put agreement to purchase Airnov Healthcare Packaging, portfolio company of Arsenal Capital Partners, a private equity firm.
The transaction, which is subject to French Works Council review and subject to necessary regulatory approvals, could close during the first quarter of 2023.
Simon Tasker, CEO, Colorcon explains, “The acquisition presents a good match for our companies as a key strength of Colorcon is the breadth of customer relationships across the pharmaceutical industry, including contacts at all levels in R&D, supply chain and procurement. The addition of Airnov would be complementary to Colorcon’s portfolio and provide synergies in terms of technical, customer and regulatory support to accelerate our customers’ product development and commercialization.”
Matthias Brommer, president and managing director, Airnov says, “Colorcon’s ownership would bring improved geographic coverage and provide our customers added value through their pharma focus and complementary product portfolio. Colorcon understands the impact of speed to market in the competitive, fast-paced pharmaceutical industry and would help us to support our customers in the production of highly effective products in reduced time frames.”
This contemplated acquisition reflects Colorcon’s goal to invest in innovative solutions that help its customers increase speed to market while leveraging Colorcon’s scale and infrastructure to deliver dependability and consistency for the supply of health and wellness products around the world.
The transaction, which is subject to French Works Council review and subject to necessary regulatory approvals, could close during the first quarter of 2023.
About Airnov
Airnov provides critical healthcare industries with high-quality, controlled atmosphere packaging, to protect their products from moisture and oxygen; this includes customizable, high-quality drop-in products (canisters and packets), integrated desiccant systems and specially designed plastic bottles containing oxygen barrier materials. The business has manufacturing facilities in the USA, France, China and India and employs around 700 people. This aligns well with Colorcon’s portfolio and its purpose to improve health and wellness through convenience, compliance and safety.Simon Tasker, CEO, Colorcon explains, “The acquisition presents a good match for our companies as a key strength of Colorcon is the breadth of customer relationships across the pharmaceutical industry, including contacts at all levels in R&D, supply chain and procurement. The addition of Airnov would be complementary to Colorcon’s portfolio and provide synergies in terms of technical, customer and regulatory support to accelerate our customers’ product development and commercialization.”
Matthias Brommer, president and managing director, Airnov says, “Colorcon’s ownership would bring improved geographic coverage and provide our customers added value through their pharma focus and complementary product portfolio. Colorcon understands the impact of speed to market in the competitive, fast-paced pharmaceutical industry and would help us to support our customers in the production of highly effective products in reduced time frames.”
This contemplated acquisition reflects Colorcon’s goal to invest in innovative solutions that help its customers increase speed to market while leveraging Colorcon’s scale and infrastructure to deliver dependability and consistency for the supply of health and wellness products around the world.
